# Amphenol Corp: Form 10-Q for the period ended Mar 31, 2017

- Company: [Amphenol Corp](/companies/aph.md) (CIK 820313)
- Form: 10-Q
- Filed: 2017-05-04
- Accepted by EDGAR: May 4, 2017, 16:50 ET
- Period: 2017-03-31
- Accession: 0001558370-17-003547
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/820313/000155837017003547/aph-20170331x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/820313/000155837017003547/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 3 months, 2017-01-01 to 2017-03-31 | $515.9m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2017-01-01 to 2017-03-31 | $201.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-01-01 to 2017-03-31 | $314.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2017-01-01 to 2017-03-31 | $19.3m | us-gaap:InterestExpense |
| Income tax | 3 months, 2017-01-01 to 2017-03-31 | $71.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-01-01 to 2017-03-31 | $224.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-01-01 to 2017-03-31 | $0.71 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-01-01 to 2017-03-31 | $0.73 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-01-01 to 2017-03-31 | 316,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 3 months, 2017-01-01 to 2017-03-31 | $48.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2017-01-01 to 2017-03-31 | $49.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2017-01-01 to 2017-03-31 | $249.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-03-31 | $1.24bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-03-31 | $3.72bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-03-31 | $8.71bn | us-gaap:Assets |
| Current liabilities | at 2017-03-31 | $1.58bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2017-03-31 | $2.86bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2017-03-31 | $375.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2017-03-31 | $3.70bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,698 characters.

### Repurchase of Equity Securities

On January 24, 2017, the Company’s Board of Directors authorized a new stock repurchase program under which the Company may purchase up to $1.0 billion of the Company’s Common Stock during the two-year period ending January 24, 2019 in accordance with the requirements of Rule 10b-18 of the Exchange Act (the “2017 Stock Repurchase Program”). During the three months ended March 31, 2017, the Company repurchased 3.7 million shares of its common stock for $249.2 million. These treasury shares have been retired by the Company and common stock and retained earnings were reduced accordingly. The Company has not repurchased any additional shares of its common stock through April 28, 2017. The price and timing of any future purchases under the 2017 Stock Repurchase Program will depend on factors such as levels of cash generation from operations, the volume of stock option exercises by employees, cash requirements for acquisitions, dividends, economic and market conditions and stock price. The table below reflects the Company’s stock repurchases for the three months ended March 31, 2017:

*(dollars in millions, except price per share)*

| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs |
| --- | ---: | ---: | ---: | ---: |
| January 1 to January 31, 2017 | — | $— | — | $1,000.0 |
| February 1 to February 28, 2017 | 3,678,365 | 67.74 | 3,678,365 | 750.8 |
| March 1 to March 31, 2017 | — | — | — | 750.8 |
| Total | 3,678,365 | $67.74 | 3,678,365 | $750.8 |

## Market risk

As filed, 1,391 characters.

The Company, in the normal course of doing business, is exposed to a variety of risks, including market risks associated with foreign currency exchange rates and changes in interest rates. The Company does not have any significant concentration with any one counterparty. There has been no material change in the Company’s assessment of its sensitivity to foreign currency exchange rate risk since its presentation set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” in its 2016 Annual Report. The Company may borrow under its Revolving

Credit Facility and Commercial Paper Program. Any borrowings under the Revolving Credit Facility either bear interest at or trade at rates that fluctuate with a spread over LIBOR, while any borrowings under the Commercial Paper Program are subject to floating interest rates. Therefore, when the Company borrows under these debt instruments, the Company is subject to market risk from exposure to changes in interest rates. As of March 31, 2017, there were no outstanding borrowings under the Revolving Credit Facility, while borrowings under the Commercial Paper Program were at an average floating rate of 1.21%. The Company does not expect changes in interest rates to have a material effect on income or cash flows in 2017, although there can be no assurances that interest rates will not change significantly.

## Controls and procedures

As filed, 1,295 characters.

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures, pursuant to Rules 13a-15(e) or 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this report. These controls and procedures are designed to provide reasonable assurance that information is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms and such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report. There has been no change in our internal control over financial reporting during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 134 characters.

There have been no material changes to the Company’s risk factors as disclosed in Part I, Item 1A of the Company’s 2016 Annual Report.

Filed May 4, 2017.
Source: SEC EDGAR, the filing index for accession 0001558370-17-003547. Last ingested by Listed: Nov 3, 2026, 18:42 ET. No prices; not investment advice.
